Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer models

105

Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer models

Tags:

Previous Article

Increased cholesterol synthesis drives neurotoxicity in multiple sclerosis

Animal model for antitumor immunity in lung cancer

Related Posts

Tumor cell-adipocyte gap junctions activate lipolysis and contribute to breast tumorigenesis

Tumor cell-adipocyte gap junctions activate lipolysis a...

101

Immune aging impairs muscle regeneration via macrophage-derived anti-oxidant selenoprotein P

Immune aging impairs muscle regeneration via macrophage...

132

Gut Microbiota and Dysbiosis in Alzheimer’s Disease: Implications for Pathogenesis and Treatment

Gut Microbiota and Dysbiosis in Alzheimer’s Disease: Im...

174